An endogenous detoxification mechanism in Tay-Sachs disease through taurine-conjugation of ganglioside GM2

被引：0
|
作者：
Li, Yu-Teh [1 ]
Li, Su-Chen [1 ]
Crawford, Byron [2 ]
Ficarra, Mercedes [2 ]
Andersson, Hans [3 ]
机构：
[1] Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA
[2] Tulane Univ, Sch Med, Dept Pathol, New Orleans, LA 70112 USA
[3] Tulane Univ, Sch Med, Human Genet Program, New Orleans, LA 70112 USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2009年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2008.11.081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
80
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [21] JUVENILE GM2 GANGLIOSIDOSIS - BIOCHEMICAL AND ULTRASTRUCTURAL STUDIES ON A NEW VARIANT OF TAY-SACHS DISEASE
    MENKES, JH
    OKADA, S
    GRIPPO, J
    ANDREWS, JM
    CANCILLA, PA
    ARCHIVES OF NEUROLOGY, 1971, 25 (01) : 14 - &
  • [22] THE MUTATIONS IN ASHKENAZI JEWS WITH ADULT GM2 GANGLIOSIDOSIS, THE ADULT FORM OF TAY-SACHS DISEASE
    NAVON, R
    PROIA, RL
    SCIENCE, 1989, 243 (4897) : 1471 - 1474
  • [23] Human Neu3 Sialidase Reduces GM2 Ganglioside Accumulation in Neuroglia Cells of Tay-Sachs Disease Mice Model
    Basirli, Hatice Hande
    Ozgur, Melike Can
    Seyrantepe, Volkan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1795 - 1795
  • [24] Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model
    Martino, S
    Cavalieri, C
    Emiliani, C
    Dolcetta, D
    De Angelis, MGC
    Chigorno, V
    Severini, GM
    Sandhoff, K
    Bordignon, C
    Sonnino, S
    Orlacchio, A
    NEUROCHEMICAL RESEARCH, 2002, 27 (7-8) : 793 - 800
  • [25] DIAGNOSIS OF TAY-SACHS DISEASE USING [H-3] N-ACETYLNEURAMINIC ACID LABELED GM2 GANGLIOSIDE AS SUBSTRATE
    POULOS, A
    HOLDING, J
    CAREY, WF
    CLINICA CHIMICA ACTA, 1982, 120 (03) : 331 - 340
  • [26] Demonstration of the in cellulo efficacy of pyrimethamine as a pharmacological chaperone for late onset Tay-Sachs Disease using a fluorescent GM2 ganglioside analogue
    Mahuran, Don
    Tropak, Michael
    Bukovac, Scott
    Rigat, Brigitte
    Yonekawa, Sayuri
    Wakarchuk, Warren
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S26 - S26
  • [27] Treatment with recombinant human lysosomal ßhexosaminidase reduces GM2 accumulation in Tay-Sachs disease cells
    Inci, Orhan Kerim
    Leal, Andres F.
    Ates, Nurselin
    Suarez, Diego
    Espejo, Angela J.
    Almeciga-Diaz, Carlos Javier
    Seyrantepe, Volkan
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [28] Unravelling the differences between infantile Tay-Sachs and Sandhoff disease using the GM2 Disease Registry (GM2DR)
    Lewi, Daniel
    Furegato, Martina
    Brignoli, Lysel
    Matos, Joana E.
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S64 - S64
  • [29] Infantile Monosialoganglioside2 (GM2) Gangliosidosis With Concurrent Bronchopneumonia: An Extraordinary Case of Tay-Sachs Disease
    Grezenko, Han
    Al-Deir, Shadi S.
    Eshete, Filagot D.
    Faran, Nuzhat
    Mimms, Ciara S.
    Ibrahim, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [30] Storage of GM2 ganglioside and altered gene expression in infantile Tay-Sachs disease during fetal development has implications for therapeutic timing and efficacy
    Han, Sangwoo T.
    Nicoli, Elena-Raluca
    Kono, Mari
    Toro, Camilo
    Proia, Richard L.
    Tifft, Cynthia J.
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S53 - S53
12345